Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in a patient with idiopathic myelofibrosis

Journal of Gastroenterology

Volumn 31, Issue 2, 1996, Pages 260-262

  Takasaki, Motohiro ^a   Takahashi, Isao ^a   Takamatsu, Masahiro ^a   Yorimitsu, Seiichi ^a   Yorimitsu, Yukio ^a   Takeda, Isao ^a   Horimi, Tadashi ^a  

^a National Hospital Organization   (Japan)

Author keywords

Endoscopic injection sclerotherapy; Esophageal varices; Idiopathic myelofibrosis; Portal hypertension

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL FEATURE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMATEMESIS; HUMAN; MELENA; MYELOFIBROSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLEEN BLOOD FLOW;

AGED; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FATAL OUTCOME; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MYELOFIBROSIS; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 0029929471     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02389527     Document Type: Article

References (14)

1. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971;50: 357-420.
2. Nakai GS, Craddock CG, Figueroa WG Agnogenic myeloid metaplasia. A survey of twenty-nine cases and a review of the literature. Ann Intern Med 1962;57:419-440.
3. Sullivan A, Rheinlander H, Weintraub LR. Esophageal varices in agnogenic myeloid dysplasia: Disappearance after splenectomy. Gastroenterology 1974;66:429-432.
4. Roux D, Merlio JP, Quinton A, et al. Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities. Gastroenterology 1987;92:1067-1072.
5. Dagradi AE, Siemsen J, Brook J, et al. Bleeding esophageal varices in myelofibrosis. Am J Gastroenterol 1965;44:536-544.
6. Silverstein MN, Gomes MR, Remie WH, et al. Agnogenic myeloid metaplasia. Natural history and treatment. Arch Intern Med 1967;120:546-550.
7. Fedeli G, Certo M, Cannizzaro O, et al. Etramedullary hematopoiesis involving the esophagus in myelofibrosis. Am J Gastroenterol 1990;85:1512-1514.
8. Block M, Jacobson LO. Myeloid metaplasia JAMA. 1950;143: 1390-1396.
9. Benbassat J, Penchas S. "Early" splenectomy and survival in agnogenic myeloid metaplasia - an analysis of 338 cases published since 1940. Acta Haematol 1981;65:189-192.
10. Lopez-Guillermo A, Cervantes F, Bruguera M, et al. Liver dysfunction following splenectomy in idiopathic myelofibrosis: A study of 10 patients. Acta Haematol 1991;85:184-188.
11. Takase Y, Ozaki A, Orii K, et al. Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery. Surgery 1982;92:474-479.
12. Terblanche J, Northover JMA, Bornman P, et-al. A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery 1979;85:239-245.
13. Paquet KJ, Busing V, Wobser E. Endoskopische befunde und therapietaktik bei osteomyelosklerose mit portaler hypertension und ösophagusvarizenblutung. Leber Magen Darm 1976;6: 358-360.
14. Jacobs P, Maze S, Tayob F, et al. Myelofibrosis, splenomegaly, and portal hypertension. Acta Haematol 1985;74:45-48.